Page last updated: 2024-12-04
4-aminobutylphosphonic acid
4-Aminobutylphosphonic acid (ABP) is a naturally occurring amino phosphonic acid with significant biological activity. It is an analog of γ-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain. ABP exhibits unique chemical properties and biological functions, making it a subject of interest in various research fields.
ABP's synthesis is often achieved through enzymatic or chemical routes. Enzymatic synthesis utilizes enzymes like phosphoenolpyruvate carboxykinase (PEPCK) and pyruvate carboxylase to produce ABP from L-aspartate. Chemical synthesis involves reactions like the condensation of phosphorous acid with 4-aminobutylbromide.
ABP's biological effects include:
- Inhibition of GABA transaminase, an enzyme involved in GABA degradation, leading to increased GABA levels in the brain.
- Modulation of neurotransmitter release, affecting synaptic transmission.
- Antiviral and antibacterial activity, particularly against certain pathogens.
- Potential for therapeutic applications in treating neurological disorders like epilepsy and Alzheimer's disease.
The importance of ABP lies in its structural resemblance to GABA and its unique biological effects. It serves as a model compound for studying the structure-activity relationships of GABA analogs and for investigating their potential therapeutic applications.
Research focuses on understanding ABP's mechanism of action, exploring its biological properties, and investigating its potential use in drug development. Studies on ABP are driven by its:
- Potential to modulate neurotransmitter function and treat neurological disorders.
- Antiviral and antibacterial activity, offering a potential alternative to conventional antibiotics.
- Unique chemical properties, enabling its use as a probe for studying enzyme activity.
- Role in understanding the evolution and biological diversity of phosphorus-containing compounds.'
Cross-References
ID Source | ID |
PubMed CID | 1726 |
SCHEMBL ID | 745120 |
MeSH ID | M0212448 |
Synonyms (17)
Synonym |
4-aminobutylphosphonic acid , |
4-abpa |
phosphonic acid, (4-aminobutyl)- |
4-aminobutylphosphonic acid, >=99% |
35622-27-6 |
(4-aminobutyl)phosphonic acid |
AKOS006275142 |
c4h12no3p |
SCHEMBL745120 |
AM85054 |
CS-W019288 |
phosphonic acid, p-(4-aminobutyl)- |
mfcd00063426 |
DTXSID80189100 |
AS-59050 |
(4-aminobutyl)phosphonicacid |
PD075497 |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 17.84
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 17.84 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.45 (4.65) | Search Engine Demand Index | 10.37 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |